A protein found in brown fat, but not typical white fat, is key to how the energy-burning brown fat cells function
While most fat cells in the human body store energy, everyone has a small subset of brown fat cells that do the opposite—burn energy and generate heat. Now, Salk researchers have discovered how the molecule ERR? gives this “healthier” brown fat its energy-expending identity, making those cells ready to warm you up when you step into the cold, and potentially offering a new therapeutic target for diseases related to obesity. The paper appears in Cell Reports on March 13, 2018.
“This not only advances our understanding of how the body responds to cold, but could lead to new ways to control the amount of brown fat in the body, which has links to obesity, diabetes and fatty liver disease,” says senior author Ronald Evans, Howard Hughes Medical Institute investigator and holder of Salk’s March of Dimes Chair in Molecular and Developmental Biology.
Until about a decade ago, scientists thought that only babies—who can’t yet shiver to warm up—had brown fat in their bodies. Studies have since shown that adults also have brown fat, albeit at much lower levels, and people with lower body mass indexes (BMIs) tend to have more of it. At a cellular level, brown fat cells are crammed full of energy-generating mitochondria, which give the cells their brown color.
In the new work, Evans’ group focused on estrogen-related receptor gamma (ERR?), a gene that is active at high levels in brown fat cells.
“We were interested in what maintains brown fat, even when we’re not exposed to cold all the time,” says Maryam Ahmadian, a Salk research associate and first author of the new paper.
The team found that brown fat cells express the ERR? gene all the time (not just in response to cold) and that white fat cells do not express the gene at all. And by studying mice lacking the gene for ERR? (and therefore unable to make the ERRy molecule), the team observed that all brown fat cells resembled white cells in these mice. Additionally, the animals were unable to maintain their body temperature when exposed to cold temperatures. While 80 percent of normal mice are able to handle a temperature drop, all mice lacking ERR? did not tolerate the cold. However, there was no difference in the metabolism or weight of the mice. Together, the experiments reveal that ERR? is key to helping brown fat maintain its identity and its ability to respond to cold.
Since the ERR? gene codes for a protein that can travel into the cell nucleus and directly control the expression of other genes, the team also probed which genes were mediated by ERR? in brown fat cells. They pinpointed a number of genes already known to be important in brown fat, but which hadn’t been specifically linked to ERR? inthe past.
“We uncovered the factors that are both involved in protection against the cold and underpin brown fat identity,” says Michael Downes, a Salk senior scientist and co–senior author of the paper.
The group is planning future studies that look at the effect of activating ERR? in white fat cells—which they suspect could make some white fat resemble brown fat, and potentially help treat obesity and diabetes. They also want to study whether the role of ERR? in the brown fat of humans is the same as what they’ve observed in mice.
The Latest on: Drug for obesity
via Google News
The Latest on: Drug for obesity
- NLRP12 protein promotes healthy gut bacteria to curb obesity on September 20, 2018 at 2:08 am
Scientists have discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet… Scientists from the UNC Schoo... […]
- Everything You Know About Obesity Is Wrong on September 19, 2018 at 3:27 am
This belief is cartoonishly out of step with a generation of research into obesity and human behavior. As one of the (many) stigma researchers who responded to Callahan’s article pointed out, shaming ... […]
- Global Anti-Obesity Drugs Industry Report 2018: Analysis & Forecasts through 2013-2023 with a Focus on the Chinese Market - ResearchAndMarkets.com on September 14, 2018 at 11:13 am
DUBLIN--(BUSINESS WIRE)--Sep 14, 2018--The "Global and Chinese Anti-Obesity Drugs Industry, 2018 Market Research Report" report has been added to ResearchAndMarkets.com's offering. The report provides ... […]
- Obesity alters airway muscle function, increases asthma risk on September 12, 2018 at 9:06 pm
Obesity is a major risk factor for asthma ... a chemical the immune system makes in response to an allergen, and carbachol, a drug that stimulates the part of the nervous system that controls the airw... […]
- Case to Watch: 7th Circuit will weigh ADA protections for obese workers on September 12, 2018 at 8:15 pm
Nearly 40 percent of U.S. adults are obese, and a ruling that obesity is a disability could open employers up to a wave of lawsuits, business groups have said in similar cases. But Mark Richardson, a ... […]
- Guest Commentary: Drug abuse, obesity prevention begins with children on September 11, 2018 at 10:01 am
In this guest commentary from the Liver Health Initiative, Thelma King Thiel, RN, BA, former CEO of both the American Liver Foundation and the Hepatitis Foundation International, gives insight into sp... […]
- Semaglutide Can Prove To Be A Very Profitable Drug For Novo Nordisk In Future Years on September 1, 2018 at 11:47 pm
Saxenda has already emerged as a leading anti-obesity medication in the world. Novo Nordisk has developed a broad research pipeline in the anti-obesity indication. The company is also targeting associ... […]
- Scientists develop a DRUG that prevents weight gain, in a 'major step' towards combating obesity on August 21, 2018 at 8:00 am
A pill to stop obesity may be on the horizon after the discovery of a protein that makes people fat. It would be the 'holy grail' of modern medicine - helping reduce the risk of heart disease, cancer, ... […]
- New enzyme discovery may help improve drugs against cancer, diabetes and obesity on July 26, 2018 at 2:40 am
A new study reveals that several drugs for treating haematological cancers are less effective than expected in inhibiting a special enzyme. Researchers have also identified new lead compounds that cou... […]
via Bing News